Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes

Patients with type 2 diabetes (T2D) are at an increased risk of morbidity and mortality of coronavirus disease 2019 (COVID-19). Data on the antibody response to COVID-19 vaccines in T2D patients are less studied. This study aimed to evaluate IgG antibody response to inactivated COVID-19 vaccines in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaoying, Lu, Huixia, Sang, Miaomiao, Qiu, Shanhu, Yuan, Yang, Wu, Tongzhi, Chen, Junhao, Sun, Zilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026888/
https://www.ncbi.nlm.nih.gov/pubmed/36864628
http://dx.doi.org/10.1080/21645515.2023.2184754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026888/
https://www.ncbi.nlm.nih.gov/pubmed/36864628
http://dx.doi.org/10.1080/21645515.2023.2184754

Ejemplares similares